Roflumilast demonstrated effectiveness and safety in treating psoriasis, with added benefits for patients with comorbidities.

The Department of Veterans Affairs (VA) saved $67 million in 2023 through its strong adoption of biosimilars to curb the high ...

More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...